鲁抗医药：2024年净利润同比预增42%—69%

Core Viewpoint - Lu Kang Pharmaceutical (600789) is expected to achieve a net profit of 350 million to 415 million yuan in 2024, representing a year-on-year increase of 42% to 69% [1] Group 1: Financial Performance - The company anticipates significant growth in sales revenue from its main products compared to the previous year [1] - The expected pre-tax income from land reserve is projected to be 156 million yuan following the completion of land transfer procedures for the southern plant [1]